Ropinirole may slow ALS progression.
Early treatment with ropinirole, a medication used to treat Parkinson’s disease, may slow disease progression in amyotrophic lateral sclerosis (ALS) patients, according to recently published data from a Phase 1/2 trial. Patients given the therapy showed slower functional declines and delayed disease progression over those who started treatment after a six-month delay. The findings support the potential utility of repurposing ropinirole for ALS, but more studies are needed to confirm its effectiveness.